Passage Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	55	55	75	344	1,164
Market Cap Growth	43.50%	-26.45%	-78.09%	-70.49%	-
Enterprise Value	-23	-33	-87	28	860
PE Ratio	-	-0.54	-0.55	-1.85	-10.37
PB Ratio	0.53	0.50	0.37	1.08	3.82
P/FCF Ratio	-1.00	-0.71	-0.61	-2.25	-14.17
P/OCF Ratio	-1.00	-0.71	-0.64	-2.71	-14.46
EV/EBITDA Ratio	0.04	0.33	0.66	-0.15	-7.71
EV/EBIT Ratio	0.04	0.32	0.64	-0.15	-7.66
EV/FCF Ratio	0.04	0.42	0.71	-0.18	-10.46
Debt / Equity Ratio	0.25	0.24	0.13	-	-
Debt / EBITDA Ratio	-0.33	-0.27	-0.20	-	-
Debt / FCF Ratio	-0.35	-0.34	-0.22	-	-
Quick Ratio	8.14	6.99	10.33	10.70	14.40
Current Ratio	8.43	7.22	10.74	11.02	14.98
Return on Equity (ROE)	-68.50%	-73.10%	-57.00%	-48.60%	-32.20%
Return on Assets (ROA)	-51.60%	-56.20%	-47.50%	-44.90%	-30.80%
Return on Capital (ROIC)	-64.28%	-74.19%	-59.58%	-58.28%	-37.05%
Earnings Yield	-152.22%	-184.33%	-180.82%	-53.96%	-9.64%
FCF Yield	-134.97%	-141.62%	-164.03%	-44.39%	-7.06%
Buyback Yield / Dilution	-3.07%	-0.58%	-2.03%	-38.14%	-811.60%
Total Shareholder Return	-3.07%	-0.58%	-2.03%	-38.14%	-811.60%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).